Kindra Scanlon
Family · Battle Ground, WANPI 1154619260
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 8 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 8 manufacturers reported payments, led by Bsn Medical Inc at 34.3% of the total. That places this record below the midpoint for family clinicians in WA, where the typical reported total is $174.
Across 8 payments — averaging $26.27 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Bsn Medical Inc$72
- Medtronic$28
- Convatec Inc.$25
- Smith+Nephew$21
- Tactile Systems Technology Inc$19
- Molnlycke Health Care US, LLC$16
- plus $28 from 2 others
What the payments were for
- Food & beverage$210100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Bsn Medical Inc | 1 | $72 |
| Medtronic | 1 | $28 |
| Convatec Inc. | 1 | $25 |
| Smith+Nephew | 1 | $21 |
| Tactile Systems Technology Inc | 1 | $19 |
| Molnlycke Health Care US, LLC | 1 | $16 |
| KCI USA, Inc. | 1 | $14 |
| Urgo Medical North America, LLC | 1 | $14 |
How this compares
$210 in reported general payments places this provider in the 50th percentile of 1,706 family providers in Washington.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Albuterol Sulfate HfaAlbuterol Sulfate | 20 | $596 |
| Nystatin | 17 | $246 |
| Levothyroxine Sodium | 24 | $212 |
| Rosuvastatin Calcium | 14 | $164 |
| Glipizide | 14 | $153 |
| Atorvastatin Calcium | 15 | $87 |
| Amlodipine Besylate | 11 | $60 |
| Metformin Hcl | 12 | $28 |
Paid to pharmacies, not to this prescriber.
Other family in Battle Ground
- Sharla PetersonKenmore$192K
- Zelda SwainSpokane$83K
- Savannah MorganRenton$76K
- Kevan PettersonSeattle$56K
- Kelly McFeeSunnyside$42K
- Cheryl SomersSpokane$31K
- Hye-Jin GehringBellevue$30K
- Kaitlin BrasierSeattle$29K
- Karen JohnsonSeattle$16K
- Brittanee WorthySpokane Valley$15K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.